Grown Rogue International (GRUSF) Depreciation & Amortization (CF) (2009 - 2026)

Grown Rogue International's (GRUSF) quarterly Depreciation & Amortization (CF) came in at $91162.0 in Q1 2026, down 20.13% year-on-year from $114135.0 in Q1 2025, and up 100.0% quarter-over-quarter from -$354.5 billion in Q4 2025.

Grown Rogue International (GRUSF) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

Grown Rogue International's Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $91162.0 for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 20.13% year-over-year to $91162.0 in Q1 2026; TTM through Mar 2026 was -$233.3 billion, a 189.13% decrease from a year earlier, with the FY2025 full-year figure at $702258.0, down 29.31% from the prior year.
  • Depreciation & Amortization (CF) climbed to $91162.0 in Q1 2026 per GRUSF's latest filing, from -$354.5 billion in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $261.8 billion in Q3 2024 and bottomed at -$354.5 billion in Q4 2025.
  • The 5-year median for Depreciation & Amortization (CF) is $119159.0 (2025), against an average of $2.2 billion.
  • Across the five-year window, Depreciation & Amortization (CF) plunged 58.18% in 2022 and jumped 122.34% in 2023, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $52010.0 in 2022, then surged by 790.22% to $463002.0 in 2023, then jumped by 56533133.12% to $261.8 billion in 2024, then plunged by 235.44% to -$354.5 billion in 2025, then jumped by 100.0% to $91162.0 in 2026.
  • Per Business Quant, the three latest GRUSF Depreciation & Amortization (CF) figures stand at $91162.0 (Q1 2026), -$354.5 billion (Q4 2025), and $121.2 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn 91,162.00

Historic Data

Download Data
DateValue
Mar 31, 2026 91,162.00
Mar 31, 2026 91,162.00
Dec 31, 2025 -354.53 Bn
Dec 31, 2025 -354.53 Bn
Sep 30, 2025 121.23 Bn
Sep 30, 2025 121.23 Bn
Jun 30, 2025 119,159.00
Jun 30, 2025 119,159.00
Mar 31, 2025 114,135.00
Mar 31, 2025 114,135.00
Sep 30, 2024 261.75 Bn
Sep 30, 2024 261.75 Bn
Jun 30, 2024 154,484.88
Jun 30, 2024 154,484.88
Mar 31, 2024 255,052.00
Mar 31, 2024 255,052.00
Oct 31, 2023 463,002.00
Oct 31, 2023 463,002.00
Jul 31, 2023 264,183.00
Jul 31, 2023 264,183.00